"10.1371_journal.pone.0070984","plos one","2013-08-06T00:00:00Z","Eleonor Tiblad; Agneta Taune Wikman; Gunilla Ajne; Agneta Blanck; Yvonne Jansson; Anita Karlsson; Elisabeth Nordlander; Bibi Shassti Holl√§nder; Magnus Westgren","Department of Clinical Science Intervention and Technology, Division of Obstetrics and Gynecology, Karolinska Institutet, Stockholm, Sweden; Department of Laboratory Medicine, Division of Clinical Immunology and Transfusion Medicine, Karolinska Institutet, Stockholm, Sweden; Department of Obstetrics and Gynecology, Karolinska University Hospital, Stockholm, Sweden; Department of Clinical Immunology and Tranfusion Medicine, University Hospital, Stockholm, Sweden","Conceived and designed the experiments: ET ATW GA AB EN MW. Performed the experiments: ET ATW GA AB YJ AK EN BSH MW. Analyzed the data: ET ATW GA AB EN MW. Contributed reagents/materials/analysis tools: ET ATW GA YJ AK BSH MW. Wrote the paper: ET ATW GA AB YJ AK EN BSH MW. Approved the final manuscript: ET ATW GA AB YJ AK EN BSH MW.","The study was funded by a research grant from Stockholm County Council. The anti-D immunoglobulin used as routine antenatal anti-D prophylaxis was sponsored by the pharmaceutical company Octapharma Nordic AB. Neither the funder nor the sponsor had any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","08","Eleonor Tiblad","ET",9,TRUE,6,9,6,9,TRUE,TRUE,FALSE,0,NA,FALSE
